CRL vs MOH: fair value comparison
Charles River Laboratories International, Inc. and Molina Healthcare, Inc. · Updated 2026-10-19
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, MOH currently sits closer to the top of our ranking by discount to fair value.
| CRL | MOH | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $301.79 | $180.85 |
| 12-month range | $149.93–$310.77 | $122.65–$242.88 |
| Rank by discount to fair value | #108 of 108 Healthcare | #88 of 108 Healthcare |
| Quality grade | F | F |
| Leverage | Moderate | Moderate |
| Margin trend | Stable | Expanding |
| Revenue growth | Declining | Modest |
| RSI zone | Neutral | Neutral |
| 52-week position | The top quarter | The lower-middle quarter |
Full single-stock breakdowns: CRL fair value analysis · MOH fair value analysis